Aclaris Therapeutics Inc. logo

Aclaris Therapeutics Inc. (8AT)

Market Closed
9 Apr, 20:00
1. 12
+0.01
+0.95%
281.5M Market Cap
- P/E Ratio
0% Div Yield
0 Volume
-1.64 Eps
1.11
Previous Close
Day Range
1.01 1.12
Year Range
0.92 4.53
Earnings results expected in 56 days
Want to track 8AT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Aclaris Therapeutics Inc. logo
ACRS Aclaris Therapeutics Inc.
6 Jun 2025 (56 Days)
-
Cons. EPS
-
EPS
Aclaris Therapeutics Inc. logo
ACRS Aclaris Therapeutics Inc.
25 Feb 2025
-
Cons. EPS
-
EPS
Aclaris Therapeutics Inc. logo
ACRS Aclaris Therapeutics Inc.
4 Nov 2024
-
Cons. EPS
-
EPS
Aclaris Therapeutics Inc. logo
ACRS Aclaris Therapeutics Inc.
7 Aug 2024
-
Cons. EPS
-
EPS
Aclaris Therapeutics Inc. logo
ACRS Aclaris Therapeutics Inc.
5 Aug 2024
-
Cons. EPS
-
EPS
Aclaris Therapeutics Inc. logo
ACRS Aclaris Therapeutics Inc.
6 Jun 2024
-
Cons. EPS
-
EPS
Aclaris Therapeutics Inc. logo
ACRS Aclaris Therapeutics Inc.
27 Feb 2024
-
Cons. EPS
-
EPS
Aclaris Therapeutics Inc. logo
ACRS Aclaris Therapeutics Inc.
23 Feb 2024
-
Cons. EPS
-
EPS
Aclaris Therapeutics Inc. logo
ACRS Aclaris Therapeutics Inc.
21 Feb 2024
-
Cons. EPS
-
EPS
Aclaris Therapeutics Inc. logo
ACRS Aclaris Therapeutics Inc.
6 Nov 2023
-
Cons. EPS
-
EPS